-
1
-
-
0034011569
-
Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder
-
American Academy of Pediatrics, Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperactivity Disorder Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/ hyperactivity disorder Pediatrics 105 2000 1158 1170
-
(2000)
Pediatrics
, vol.105
, pp. 1158-1170
-
-
-
2
-
-
0036154701
-
Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina
-
A.S. Rowland, D.M. Umbach, L. Stallone, J. Naftel, M. Bohlig, and D.P. Sandler Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina Am J Public Health 92 2002 231 234
-
(2002)
Am J Public Health
, vol.92
, pp. 231-234
-
-
Rowland, A.S.1
Umbach, D.M.2
Stallone, L.3
Naftel, J.4
Bohlig, M.5
Sandler, D.P.6
-
3
-
-
0000624888
-
The behavior of children receiving benzedrine
-
C. Bradley The behavior of children receiving benzedrine Am J Psychiatry 94 1937 577 585
-
(1937)
Am J Psychiatry
, vol.94
, pp. 577-585
-
-
Bradley, C.1
-
4
-
-
3042622074
-
Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder
-
American Academy of Pediatrics, Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperactivity Disorder Clinical practice guideline: treatment of the school-aged child with attention-deficit/ hyperactivity disorder Pediatrics 108 2001 1033 1044
-
(2001)
Pediatrics
, vol.108
, pp. 1033-1044
-
-
-
5
-
-
0036483615
-
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults
-
American Academy of Child and Adolescent Psychiatry Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults J Am Acad Child Adolesc Psychiatry 41 2002 26S 49S
-
(2002)
J Am Acad Child Adolesc Psychiatry
, vol.41
-
-
-
6
-
-
0037233358
-
Psychotropic practice patterns for youth: A 10-year perspective
-
J.M. Zito, D.J. Safer, S. dosReis, J.F. Gardner, L. Magder, and K. Soeken Psychotropic practice patterns for youth: a 10-year perspective Arch Pediatr Adolesc Med 157 2003 17 25
-
(2003)
Arch Pediatr Adolesc Med
, vol.157
, pp. 17-25
-
-
Zito, J.M.1
Safer, D.J.2
Dosreis, S.3
Gardner, J.F.4
Magder, L.5
Soeken, K.6
-
7
-
-
0033175709
-
AHA Scientific Statement: Cardiovascular monitoring of children and adolescents receiving psychotropic drugs
-
H. Gutgesell, D. Atkins, R. Barst, M. Buck, W. Franklin, and R. Humes AHA Scientific Statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs J Am Acad Child Adolesc Psychiatry 38 1999 1047 1050
-
(1999)
J Am Acad Child Adolesc Psychiatry
, vol.38
, pp. 1047-1050
-
-
Gutgesell, H.1
Atkins, D.2
Barst, R.3
Buck, M.4
Franklin, W.5
Humes, R.6
-
8
-
-
0036837114
-
Attention deficit/hyperactivity disorder and methylphenidate: A review of height/weight, cardiovascular, and somatic complaint side effects
-
M.D. Rapport, and C. Moffitt Attention deficit/hyperactivity disorder and methylphenidate: a review of height/weight, cardiovascular, and somatic complaint side effects Clin Psychol Rev 22 2002 1107 1131
-
(2002)
Clin Psychol Rev
, vol.22
, pp. 1107-1131
-
-
Rapport, M.D.1
Moffitt, C.2
-
10
-
-
1642539047
-
Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: Results from a one-year follow-up study
-
T.E. Wilens, J. Biederman, M. Lerner, and the Concerta® Study Group Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study J Clin Psychopharmacol 24 2004 36 41
-
(2004)
J Clin Psychopharmacol
, vol.24
, pp. 36-41
-
-
Wilens, T.E.1
Biederman, J.2
Lerner, M.3
-
11
-
-
0036338926
-
A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder
-
J. Biederman, F.A. Lopez, S.W. Boellner, and M.C. Chandler A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder Pediatrics 110 2002 258 266
-
(2002)
Pediatrics
, vol.110
, pp. 258-266
-
-
Biederman, J.1
Lopez, F.A.2
Boellner, S.W.3
Chandler, M.C.4
-
12
-
-
19344365581
-
Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR®) in children with ADHD
-
J.J. McGough, J. Biederman, S.B. Wigal, F.A. Lopez, J.T. McCracken, and Y. Zhang Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR®) in children with ADHD J Am Acad Child Adolesc Psychiatry 44 6 2005 in press
-
(2005)
J Am Acad Child Adolesc Psychiatry
, vol.44
, Issue.6
-
-
McGough, J.J.1
Biederman, J.2
Wigal, S.B.3
Lopez, F.A.4
McCracken, J.T.5
Zhang, Y.6
-
13
-
-
0041687626
-
Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD
-
J.T. McCracken, J. Biederman, L.L. Greenhill, J.M. Swanson, J.J. McGough, and T.J. Spencer Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD J Am Acad Child Adolesc Psychiatry 42 2003 673 683
-
(2003)
J Am Acad Child Adolesc Psychiatry
, vol.42
, pp. 673-683
-
-
McCracken, J.T.1
Biederman, J.2
Greenhill, L.L.3
Swanson, J.M.4
McGough, J.J.5
Spencer, T.J.6
-
15
-
-
0001127258
-
An analysis of time relations of electrocardiogram
-
H. Bazett An analysis of time relations of electrocardiogram Heart 7 1920 353 370
-
(1920)
Heart
, vol.7
, pp. 353-370
-
-
Bazett, H.1
-
20
-
-
0003771024
-
-
London: The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit; December 17, (Report no. CPMP/986/96).
-
Committee for Proprietary Medicinal Products. The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. London: The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit; December 17, 1997. (Report no. CPMP/986/96).
-
(1997)
The Assessment of the Potential for QT Interval Prolongation by Non-cardiovascular Medicinal Products
-
-
-
21
-
-
0027382464
-
Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States
-
B. Rosner, R.J. Prineas, J.M.H. Loggie, and S.R. Daniels Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States J Pediatr 123 1993 871 886
-
(1993)
J Pediatr
, vol.123
, pp. 871-886
-
-
Rosner, B.1
Prineas, R.J.2
Loggie, J.M.H.3
Daniels, S.R.4
-
22
-
-
0018632505
-
Normal ECG standards for infants and children
-
A. Davignon, P. Rautaharju, E. Boisselle, F. Soumis, M. Megelas, and A. Choquette Normal ECG standards for infants and children Ped Cardiol 1 1979/80 123 131
-
(1979)
Ped Cardiol
, vol.1
, pp. 123-131
-
-
Davignon, A.1
Rautaharju, P.2
Boisselle, E.3
Soumis, F.4
Megelas, M.5
Choquette, A.6
-
23
-
-
0043190430
-
Pharmacokinetics of SLI381 (Adderall XR), an extended-release formulation of Adderall
-
J.J. McGough, J. Biederman, L.L. Greenhill, J.T. McCracken, T.J. Spencer, and K. Posner Pharmacokinetics of SLI381 (Adderall XR), an extended-release formulation of Adderall J Am Acad Child Adolesc Psychiatry 42 2003 684 691
-
(2003)
J Am Acad Child Adolesc Psychiatry
, vol.42
, pp. 684-691
-
-
McGough, J.J.1
Biederman, J.2
Greenhill, L.L.3
McCracken, J.T.4
Spencer, T.J.5
Posner, K.6
-
24
-
-
0033843606
-
Circadian rhythm of heart rate and heart rate variability
-
M.M. Massin, K. Maeyns, N. Withofs, F. Ravet, and P. Gérard Circadian rhythm of heart rate and heart rate variability Arch Dis Child 83 2000 179 182
-
(2000)
Arch Dis Child
, vol.83
, pp. 179-182
-
-
Massin, M.M.1
Maeyns, K.2
Withofs, N.3
Ravet, F.4
Gérard, P.5
-
25
-
-
1642367699
-
A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study)
-
J.M. Swanson, S.B. Wigal, T. Wigal, E. Sonuga-Barke, L.L. Greenhill, and J. Biederman A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study) Pediatrics 113 3 pt 1 2004 e206 e216 Available at http://pediatrics.org/cgi/content/full/113/3/e206
-
(2004)
Pediatrics
, vol.113
, Issue.3 PART 1
-
-
Swanson, J.M.1
Wigal, S.B.2
Wigal, T.3
Sonuga-Barke, E.4
Greenhill, L.L.5
Biederman, J.6
|